RON HOOGEVEEN to Cholesterol, HDL
This is a "connection" page, showing publications RON HOOGEVEEN has written about Cholesterol, HDL.
Connection Strength
0.323
-
Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015 Mar 01; 36(9):539-50.
Score: 0.092
-
Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res. 2012 Dec; 53(12):2726-33.
Score: 0.083
-
Role of lipid and lipoprotein profiles in risk assessment and therapy. Am Heart J. 2003 Aug; 146(2):227-33.
Score: 0.044
-
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res. 2001 Apr; 42(4):631-8.
Score: 0.038
-
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61.
Score: 0.024
-
Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet. 2014 Feb 06; 94(2):198-208.
Score: 0.023
-
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602.
Score: 0.019